We speculated that some unknown mutations in KIT/PDGFRA or other genes, which failed to be detected by traditional PCR-based Sanger sequencing, may also take part in the development and therapeutic response of GIST. This evidence concerns the gene KIT and gastrointestinal stromal tumor.